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Abstract Rim protein (RmP) is a high-Mr membrane glyco-
protein that has been localized to the rims of photoreceptor outer 
segment discs, but its molecular identity is unknown. Here, we 
describe the purification of RmP and present the sequence of its 
mRNA. RmP is a new member of the ATP-binding cassette 
(ABC) transporter superfamily. We show that RmP is expressed 
specifically in photoreceptors and predominantly in outer 
segments. Further, RmP is identical to the protein recently 
shown to be affected in recessive Stargardt's disease. RmP is the 
first ABC transporter observed in photoreceptors and may play a 
role in the photoresponse. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Retinal photoreceptors contain a light-sensitive structure 
called the outer segment, comprising a dense stack of mem-
branous discs. Rim protein (RmP) is an abundant membrane 
glycoprotein of approximately 240 kDa in frog retina that is 
present in the rims of rod and cone outer segment discs [1-3]. 
A smaller protein (210 kDa) in bovine rod outer segments 
(ROS) has been assumed to be the mammalian homolog of 
frog RmP [1-6], although immunocytochemical localization of 
mammalian RmP has never been described. The function of 
RmP is unknown. It has been suggested that RmP may rep-
resent the electron-dense filaments at the disc rim that span 
the cytoplasmic space between adjacent discs [7,8], or between 
disc rim and plasma membrane [9]. RmP has also been shown 
to be phosphorylated in a light-dependent fashion [10], sug-
gesting a role in the photoresponse. 
The ABC transporters effect ATP-dependent translocation 
of specific substrates across cellular membranes. One member 
of the ABC family, the cystic fibrosis transmembrane conduct-
ance regulator (CFTR), functions as a cAMP-regulated chlo-
ride channel instead of an active transporter [11]. The ABC 
proteins are present in species ranging from Escherichia coli to 
humans [12-14], and are expressed in many cell types. The 
substrates are best defined for the E. coli transporters, and 
include sugars, metal ions, amino acids, and polypeptides 
[13]. The substrates are unknown for many of the eukaryotic 
ABC transporters. The genes for ABC transporters have also 
been implicated in several human inherited diseases. Recessive 
Stargardt's is an inherited disease that causes progressive loss 
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of central vision in children [15]. Recently, the gene for reces-
sive Stargardt's was cloned and found to encode a novel ABC 
transporter expressed in photoreceptors [16]. In this report, we 
show that RmP is a new member of the ATP-binding cassette 
(ABC) transporter superfamily, and is identical to the pre-
dicted product of the Stargardt's disease gene (ABCR). 
2. Materials and methods 
2.1. Biochemical methods 
ROS were purified from frozen bovine retinae (J. and A. Lawson, 
Lincoln, NE) as described [17], except a 25%, 35% sucrose step gra-
dient [18] was used. Dark-adapted ROS had an A280/A500 ratio of 
2.2-2.4 [17]. ROS were prepared from frozen frog (Rana catesheiana) 
retinae by the same procedure. Protein quantitation was performed 
with the BCA kit (Pierce, Rockford, IL). Proteins were separated on 
Laemmli or porous [19] SDS-PAGE gels. Standards for protein elec-
trophoresis consisted of the 10 kDa ladder (BRL, Gaithersburg, MD) 
supplemented with filamin (Sigma, St. Louis, MO). For non-reducing 
SDS-PAGE, proteins were solubilized in Laemmli sample buffer with-
out 2-mercaptoethanol (2-ME) and containing 1 mM oxidized gluta-
thione (GSSG) (Sigma, St. Louis, MO) [10]. Gels were stained and 
immunoblots were prepared as described [17]. Antibodies were diluted 
1000 to 1500-fold in TBS plus l%o BSA. Immunoreactive polypeptides 
were visualized with NBT/BCIP or with the ECL kit (Amersham, 
Arlington Heights, IL). For detecting concanavalin A (ConA)-binding 
proteins, blots were probed 1 h at 25°C with 1 μg/ml ConA-HRP 
(Sigma, St. Louis, MO) in 0.1% BSA, 0.5 mM CaCl2, 0.5 mM MnCl2, 
in TBS, and stained with the 4CN kit (KPL, Gaithersburg, MD). 
To purify RmP, ROS proteins (5 mg/gel) were subjected to SDS-
PAGE on 10% porous gels and stained in Coomassie. The RmP band 
was excised and electroeluted using Centricon 30 cartridges with the 
Centrilutor (Amicon, Beverly, MA). The eluted protein was concen-
trated in the Centricon cartridge. For amino acid sequencing, elec-
troeluted protein was subjected to SDS-PAGE, transblotted onto Im-
mobilon P (Millipore, Bedford, MA), and sent to a local facility for 
Edman degradation. For deglycosylation experiments, electroeluted 
RmP was treated with 5 U/ml endoglycosidase F (EnF) (Boehringer, 
Indianapolis, IN) in 0.25 M sodium acetate (pH 4.5), 0.1 mM EDTA, 
2.5% TX-100; or with 2 U/ml JV-glycosidase F (NgF) (Boehringer, 
Indianapolis, IN) in 100 mM Tris-HCl, pH 6.9, 30 mM EDTA, 1% 
TX-100, for 4 h at 37°C. Samples were precipitated with acetone for 
SDS-PAGE analysis. 
2.2. Molecular techniques 
Total RNA was isolated from mouse and bovine retina using Trizol 
(BRL, Gaithersburg, MD). Poly(A)+ RNA was purified from total 
RNA with the polyA Tract system (Promega, Madison, WI). Random 
and oligo(dT)-primed retinal cDNA libraries were generated in lamb-
da ZAP II (Stratagene, La Jolla, CA), according the manufacturer's 
procedure. Sequence analysis was performed on an ABI 377 auto-
mated DNA sequencer, and by using the Radiolabeled Terminator 
Cycle Sequencing kit (Amersham, Arlington Heights, IL). Both 
strands were sequenced in entirety. DNA and predicted protein se-
quences were analyzed with the DNAsis and PC Gene software pack-
ages. For Northern analysis, poly(A)+ RNA from mouse retina was 
separated by electrophoresis on 1.0% agarose formaldehyde gels, and 
transferred to nitrocellulose membranes. Blots were hybridized with 
106 cpm/ml of 32P-labeled cDNA insert fragments from RmP clone 
pRmP9A or rds clone B9A [20]. Final stringency-wash conditions 
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were 0.2XSSC, 0.1% SDS at 65°C. Labeled mRNA bands were vis-
ualized on a Molecular Dynamics Phosphor Imager after overnight 
exposures. 
To map the human RmP gene, oligonucleotide primers derived 
from the 5' untranslated region of a human RmP cDNA (Azarian 
and Travis, unpublished) were used to amplify DNA prepared from 
93 human-hamster radiation hybrid cell lines of the Genebridge 4 
panel (Research Genetics, Huntsville, AL) by PCR. The score vehicle 
was submitted via the internet to the Whitehead Institute for a map 
assignment. 
3. Results 
3.1. Biochemical identification of RmP 
We tentatively identified bovine and frog RmP as the 210-
and 240-kDa bands, visible by Coomassie staining after SDS-
PAGE of purified ROS, based on their size and abundance 
(Fig. la). On an immunoblot, these bands were reactive with 
the same antiserum against frog RmP (α-fRmP) that showed 
disc-rim localization by immunocytochemistry [1,2]. In bovine 
ROS, the 210-kDa protein was also immunoreactive with a 
polyclonal antiserum (cc-bRmPi) raised against a synthetic 
peptide corresponding to amino acids #2-16 in bovine RmP, 
derived from the sequence analysis (see below). This reactivity 
was blocked by pre-incubating the antiserum with the syn-
thetic peptide. Bovine RmP could be extracted from ROS 
membranes with Triton X-100 and CHAPS detergents, but 
not urea, confirming that it is a membrane protein. By Coo-
massie staining, the ratio of RmP/rhodopsin appeared signifi-
cantly higher in frog compared to that in bovine ROS (Fig. 
la). We confirmed our identification of bovine and frog RmP 
by demonstrating that the biochemical properties of the 210-
and 240-kDa proteins were identical to those previously re-
ported. When ROS were solubilized in Laemmli sample buffer 
containing GSSG instead of 2-ME, we observed an upward-
shift in apparent Μτ of both the bovine and frog proteins, as 
previously described [1,10] (Fig. lb). The oxidized and re-
duced forms of bovine and frog RmP reacted with ConA [4] 
and with α-fRmP. Treatment of purified bovine RmP with the 
glycosidases, EnF or NgF, caused a small reduction in appar-
ent Μτ (Fig. lc), suggesting that RmP is N-glycosylated, and 
that the N-linked glycans contribute little to its total mass. 
Collectively, these data indicate that we have correctly identi-
fied bovine and frog RmP, and show it to be an abundant 
high-Mr membrane glycoprotein that is present in photorecep-
tor outer segments. 
3.2. Purification of RmP and isolation of cDNAs 
We purified bovine and frog RmP from ROS by prepara-
tive SDS-PAGE under both oxidizing and reducing condi-
tions, followed by electroelution. These samples were submit-
ted to peptide microsequence analysis. We reasoned that if the 
RmP band were contaminated with another comigrating spe-
cies, it is very unlikely that this contaminating protein would 
demonstrate the identical redox-shift as that of RmP. The 
amino-terminal sequence obtained for bovine RmP was 
'MGFARQIKLLLXKNXT', and was identical between the 
oxidized and reduced forms. The sequence obtained for frog 
RmP was 'MRFSAKVKLLLXXNNT', which was 60% iden-
Fig. 1. Biochemical and immunological characterization of RmP. a: SDS-PAGE and immunoblot analysis of RmP in bovine (b) and frog (f) 
ROS. The first panel is a 10% porous gel stained with Coomassie. The major band labeled 'rho' is rhodopsin. ROS corresponding to 0.1 bovine 
and 0.5 frog retinae were loaded in each lane. The second and third panels are transblots of equivalent gels reacted with α-fRmP, and 
α-bRmPi. b: Oxidation-reduction (redox) behavior of RmP. First panel shows a Coomassie-stained 6% Laemmli gel containing 0.2 retina-
equivalents of bovine or 1.0 retina-equivalent of frog ROS per lane, electrophoresed in the presence of 2-ME (red) or 1 mM GSSG (oxd). 
Second panel shows transblot of similar gels reacted with ConA-HRP. Third panel shows transblot of similar gels reacted with a-fRmP. c: En-
zymatic deglycosylation of purified RmP. 6% Laemmli gel of bovine RmP digested with or without EnF or NgF. Control (ctl) lane contains 
RmP kept on ice. Positions of the Mr standards are indicated on the left in kDa. 
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Fig. 2. Northern blot analysis of retinal RNA. First panel shows a 
blot containing 5 μg of mouse retinal (mRET) poly(A)+ RNA hy-
bridized with a 1.6-kb fragment of pRmP9A. Second panel shows 
the same blot stripped and rehybridized with ri&-B9A. The two rds 
transcripts of 2.7 and 1.6 kb arise by alternative polyadenylation 
[20]. Mobilities of RNA size standards are indicated on the left in 
kb. 
tical to the bovine sequence over the common 16-residue 
stretch, with mainly conservative substitutions. These data 
confirm that the 210-kDa bovine and 240-kDa frog proteins 
are homologous. 
Degenerate antisense oligonucleotides (5'-A(A/G)NGTCC-
A(A/G)TT(G/T)TTCCA and 5'-AG(C/T)TT(A/G)ATCTG(C/ 
T)C(G/T)(A/G/T)GC) were designed by reverse-translation of 
the RmP peptide sequence and used pairwise in combination 
with T3 or T7 oligonucleotides as primers for nested PCR on 
DNA from a randomly primed bovine retinal library. Direct 
sequence analysis of the resulting amplification products gave 
a predicted amino acid sequence that was 100% identical to 
that obtained by the Edman degradation of purified RmP. 
The bovine cDNA fragment from near the 5' terminus was 
used to screen a randomly primed mouse retinal cDNA li-
brary. To obtain full-length cDNA representation, it was nec-
essary to re-screen an oligo(dT)-primed mouse library with a 
3' fragment of the initial mouse cDNA isolate. We assembled 
the composite presumed full-length mouse RmP cDNA, 
pRmP9A, from two overlapping cDNA subclones. 
3.3. RmP is an ATP-binding cassette transporter 
Clone pRmP9A contained an insert of 7290 bp. Sequence 
analysis revealed a single long open reading frame of 6930 bp, 
with an initiator codon in the Kozak consensus sequence [21], 
after a 5' untranslated region (UTR) of 84 bp. The 3'-UTR 
contained 210 bp and a consensus polyadenylation signal 
(AAUAAA), followed by a poly(A) tail. By Northern blot 
analysis of mouse retina, this cDNA detected a single 
mRNA of 7.3 kb (Fig. 2), suggesting that clone pRmP9A is 
full-length. This blot was re-hybridized with a probe, of com-
parable length and specific activity, corresponding to the well-
characterized photoreceptor-specific mRNA, rds [20] (Fig. 2). 
Based upon the isolation-frequency of RmP clones from our 
retinal libraries, we estimate that the RmP mRNA is present 
in retina at an abundance of approximately 0.01%. 
The single large open reading frame encodes a putative 
protein of 2310 residues (Fig. 3a), with significant identity 
to members of the ABC transporter family. Within the region 
of overlap, the predicted mouse protein is 93% identical to the 
N-terminus of the bovine rim protein, determined by peptide 
and cDNA sequence analysis. Primary structural analysis of 
the mouse protein showed 12 predicted membrane-spanning 
segments and three potential sites for N-linked glycosylation, 
all three within the first large extracellular (intradiscal) loop 
(Fig. 3a,b). RmP also contains two consensus ATP/GTP nu-
cleotide-binding sites (Walker A motifs) [22] and two ABC 
transporter signature motifs [23] (Fig. 3a,b). Both transporter 
motifs contain a potential site of phosphorylation by protein 
kinases A or G (PKA/PKG). A Walker B motif (RXe-g^D) 
[22] overlaps with transporter motif 1. Within the large cyto-
plasmic loop, containing the first nucleotide binding fold 
(NBF) and transporter motifs, we also observed a 22-residue 
highly hydrophobic domain (HD), containing three proline 
residues. A dot matrix similarity plot of mouse RmP against 
itself showed two stretches of incomplete duplication between 
residues 940-1160 and 1940-2150 within the NBF1 and NBF2 
cytoplasmic domains (Fig. 3c). The sequence of mouse RmP is 
86% identical (92% with substitution of similar amino acids) 
to the human ABCR protein, encoded by the gene affected in 
recessive Stargardt's disease [16]. 
3.4. Tissue distribution of RmP expression 
A polyclonal antibody raised against the complete bovine 
protein (a-bRmP4) reacted specifically with RmP on immuno-
blots containing bovine ROS and mouse retina homogenates 
(Fig. 4a). On an immunoblot containing equal protein 
amounts from various mouse tissues, a-bRmP4 showed reac-
tivity only in retina (Fig. 4b). To localize RmP within retina, 
we examined the level of immunoreactivity in samples con-
taining different cellular components. No RmP immunoreac-
tivity was observed in eyecups from 6-month-old retinal de-
generation (rd) mutant mice, which lack photoreceptors but 
contain all other retinal cell types [24] (Fig. 4c). We observed 
weak immunoreactivity in eyecups from 3-week-old retinal 
degeneration slow (rds) mutant mice, which lack outer segment 
structures, but contain all retinal cell types including photo-
receptor cell bodies [25]. When the same immunoblot was 
stripped and reacted again with an antibody (oc-bRho) against 
the outer segment protein, rhodopsin, a similar pattern was 
observed (Fig. 4c). These data suggest that RmP is present 
only in retina, where it is expressed specifically in photorecep-
tors, and predominantly if not exclusively in outer segments. 
3.5. Chromosomal localization of the RmP gene 
We determined the chromosomal localization of the human 
RmP gene using a panel of 93 human-hamster radiation hy-
brid cell lines. Matrix analysis of the hybrids containing the 
human RmP gene showed that it maps with a lod score of 21 
to human chromosome lp, 6.9 cR from the WI-3099 marker. 
This localization placed the RmP gene between the markers 
D1S424 and D1S236. Besides recessive Stargardt this is also 
within the critical region for a new form (RP19) of autosomal 
dominant retinitis pigmentosa [26,45]. By synteny, the mouse 
RmP gene maps to chromosome 3 between the loci Ly-37 [27] 
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Fig. 3. Primary structure analysis of mouse RmP. a: Amino acid sequence predicted from the cDNA. The 12 predicted membrane-spanning 
oe-helical segments are indicated with a heavy bar above the sequence and the corresponding Roman numeral below. The three predicted N-gly-
cosylation sites on the extracellular surface are indicated by Ύ'. Residues comprising the nucleotide binding sites are boxed and indicated by 
ΆΤΡΓ and ΆΤΡ2'. The transporter signature-motifs (including Walker B motif) are boxed and labeled 'ΤρΜΓ and 'TpM2'. A proline-con-
taining hydrophobic domain is indicated by double bars and 'HD'. The two PKA-phosphorylation sites are indicated by '*'. The nucleotide se-
quence of clone pRmP9A was deposited in GenBank under accession numbers AF000148 and AF000149. b: Schematic showing the predicted 
topology of RmP in the membrane. The extracellular (intradiscal) surface is on top and the cytoplasmic on bottom of the figure. Black dots in-
dicate the approximate positions of point mutations causing single-residue substitutions associated with recessive Stargardt's [16]. c: Dot-matrix 
plot of mouse RmP against itself. Note the region of incomplete duplication between residues 940-1160 and 1940-2150 within NBF1 and 
NBF2. Analysis was performed with a check size of 20 and match size of 8. Numbers on the sides denote residue positions. 
and Tshb [28]. No mouse mutants with a retinal phenotype RmP. Our identification of RmP in mammalian retina is 
have been mapped to this region of chromosome 3. based upon three observations: (i) it cross-reacts with the 
same antibody that was originally used to identify RmP in 
4. Discussion frog discs; (ii) it has biochemical properties similar to those 
of frog RmP; and (iii) it is homologous to frog RmP by 
In this paper, we present a molecular characterization of microsequence analysis. Based upon the sequence of a full-
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Fig. 4. Tissue and subcellular distribution of RmP. a:) Immunoblots 
containing homogenates of purified bovine ROS (bROS, 40 μg pro-
tein) and mouse retina (mRET, 400 μg protein) reacted with a-
bRmP.4. b: Immunoblot containing homogenates of indicated mouse 
tissues (400 μg protein) reacted with a-bRmP4. c: Immunoblots 
containing eyecup homogenates (400 μg protein) of C57BL/6 wild-
type (wt), pre-degenerate rds homozygous mutant (rds), and fully 
degenerate rd homozygous mutant (rd) mice, reacted with 0>bRmP4. 
The same blot was stripped and reacted again with a polyclonal 
antibody against bovine rhodopsin (α-bRho). Blots were generated 
from 10% porous gels. 
length cDNA, RmP is a new member of the ABC transporter 
superfamily, identical to the protein encoded by the gene for 
recessive Stargardt's disease [16]. 
In common with most eukaryotic ABC transporters, RmP 
contains 12 transmembrane segments with cytoplasmic amino 
and carboxy termini. RmP also contains two nucleotide bind-
ing sites [22], two transporter motifs [23], and a single Walker 
B motif [22], the latter in cytoplasmic loop NBF1. The two 
predicted PKA/PKG phosphorylation sites are located within 
the transporter motifs, both exactly 100 residues downstream 
of the nucleotide binding sites. The spacing between nucleo-
tide binding and transporter motifs is conserved in many ABC 
transporters [29], suggesting that this 100-residue segment is 
an important structural element. By dot matrix analysis, this 
segment is part of an imperfect duplication in cytoplasmic 
domains NBF1 and NBF2, similar to the other eukaryotic 
ABC transporters [29]. Interestingly, the preponderance of 
point mutations in recessive Stargardt's affect codons for res-
idues within these two nucleotide-binding folds [16] (Fig. 3). 
This distribution of mutations corroborates the importance of 
the NBF1 and NBF2 domains in RmP activity. 
The closest relative of RmP (besides its direct human or-
tholog) is ABC1 [29], at 49% amino acid identity. RmP and 
ABC1 share a structural feature that is not seen in the other 
ABC transporters: a highly hydrophobic domain with three 
proline residues in the NBF1 loop. It was suggested that this 
represents an integral-membrane hairpin structure in ABC1 
[29]. RmP is longer, with 60 residues at the amino terminus 
that do not align with ABC1. In addition, the first predicted 
extracellular (intradiscal) loop of RmP, which contains the 
three sites for N-linked glycosylation, is much larger in 
RmP than that predicted for ABC1 [30]. RmP thus appears 
to have all the structural features that define a eukaryotic 
ABC transporter, plus a large extracellular loop of as yet 
undefined function. The carboxy terminus of mouse RmP 
contains 37 additional residues not present in the human pro-
tein (Azarian and Travis, unpublished) [16]. 
By immunoblot analysis, RmP was expressed specifically in 
retina, and predominantly but not exclusively in outer seg-
ments. The low level of RmP expression in rds eyecups may 
reflect RmP within the inner-segment secretory pathway. 
Weak reactivity was also observed with the outer-segment 
protein, rhodopsin. No signal was detected with oc-bRmPi 
or a-bRmP4 in immunocytochemical studies, probably due 
to epitope-masking. The ratio of RmP/rhodopsin was sev-
eral-fold higher in frog than in bovine retina (assuming com-
parable Coomassie-staining of the corresponding frog and 
bovine proteins). Outer segment discs contain deep indenta-
tions, called incisures. The number of disc incisures is signifi-
cantly higher in amphibians than mammals [7,31]. Since rho-
dopsin is present in the disc lamellae but excluded from the 
rims [9], a positive correlation between the ratios of RmP/ 
rhodopsin and the disc circumference-to-disc area is consistent 
with disc-rim localization of RmP in mammalian retina. In 
one study of bovine ROS where outer segment plasma mem-
branes were biochemically separated from disc membranes, 
the 210-kDa RmP band was present in the disc-membrane 
fraction, which lacked the plasma membrane cation channel 
[32]. These observations imply a similar distribution of RmP 
in mammalian and amphibian photoreceptors. 
The function of RmP in photoreceptors remains a critical 
open question. As a recessive disorder, Stargardt's disease is 
presumably due to a loss of RmP function. The ophthalmo-
logical findings in patients with early disease is one of pure 
central-retinal (macular) degeneration [15,33-35]. The pre-
dominant histopathological changes in Stargardt's involves 
the retinal pigment epithelium [36,37]. Presumably, these 
changes are secondary to a cell-autonomous process occurring 
in photoreceptors, since RmP is expressed in photoreceptors 
but not in cells of the pigment epithelium (Fig. 4) [16]. The 
closest relative of RmP is ABC1 [29]. This widely expressed 
transporter may be required for the engulfment of cells under-
going apoptotic cell death [38]. A cellular process in retina 
related to the phagocytosis of cells undergoing apoptosis is 
the diurnal shedding and phagocytosis of distal outer seg-
ments by the pigment epithelium [39]. Although it is tempting 
to speculate that RmP, similar to ABC1, is playing a role in 
phagocytosis, the two systems are quite dissimilar. In the case 
of ABC1, it is the phagocytosing macrophage that expresses 
the transporter, while RmP is expressed in the phagocytosed 
outer segment, but not the phagocytosing pigment epithelial 
cell, since no RmP immunoreactivity was observed in rd eye-
cups. ABC1 has been shown to act as an electroneutral anion 
exchanger [30], although its physiological substrate has not 
been identified. A similar ion-transport function for RmP is 
plausible. The localization of RmP in discs places it adjacent 
to the plasma membrane, which contains the cGMP-gated 
cation channel. One hypothesis is that RmP functions to mod-
ulate the free Ca2+ concentration in outer segments, either 
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through ATP-dependent Ca 2 + uptake into discs [40], or light-
stimulated passive exchange of H + and Ca 2 + across disc mem-
branes [41,42]. R m P may also represent the light-activated 
Mg 2 + -ATPase observed in ROS [43,44]. Allikmets et al. [16] 
suggest that A B C R may function as a retinoid transporter. 
This proposed function appears less likely with our identifica-
tion of A B C R as the outer segment disc protein, R m P . De-
termining the function for R m P has become all the more 
urgent with the demonstrat ion now that it is encoded by the 
gene for recessive Stargardt 's . 
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